gdc
Cancer ResearchClinical TrialsImmunotherapy

Is CAR T-Cell Therapy Safe and Effective?

Claire White discusses the role of the FDA in evaluating new and promising treatments such as CAR T-cell therapy and the complexity of getting approvals.
Video Library – March 6, 2019
Claire White, BSN, RN, CPHON
The Children's Hospital of Philadelphia, Philadelphia, PA
Claire White discusses the role of the FDA in evaluating new and promising treatments such as CAR T-cell therapy and the complexity of getting approvals.
Recommended For You
Immunotherapy
Why Target the Immune System?
By Colleen H. Erb, MSN, CRNP, ACNP-BC, AOCNP
The immune system attacks foreign substances by making large numbers of antibodies. These are proteins that attach to a specific protein on the cell called an antigen.
Cancer Research
Nobody Fights Alone: Coast 2 Coast 4 Cancer Annual Bike Ride in Support of Cancer Research
By Kelsey Moroz
After an operation to remove a rare bone cancer on his spine, Dana Vaughns never thought he would be cycling across America to raise funds for cancer research. Dana says, “Crossing the finish line with the Coast 2 Coast 4 Cancer team will be symbolic of my victory over cancer for the past 10 years.”
ImmunotherapyMultiple Myeloma
How CAR T-Cell Therapy Gave Cherie Rineker Her Life Back
By Kelsey Moroz
Chemotherapy for multiple myeloma had kept Cherie Rineker alive for 5 years, but then she realized she was slowly dying. So she embarked on a search for a clinical trial and by luck was able to join one. To her amazement, “What 2 stem-cell transplants and 13 other treatments had not been able to do in more than 65 months, CAR T-cell therapy did in less than 1 month,” she said.
Last modified: September 10, 2019

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country